Trader’s Watch List: XOMA Corporation (NASDAQ:XOMA), CTI BioPharma Corp. (NASDAQ:CTIC), Relypsa, Inc. (NASDAQ:RLYP), General Electric Company (NYSE:GE),

XOMA Corporation (NASDAQ:XOMA), a leader in the discovery and development of antibody therapeutics, announced the Company will host a conference call on Wednesday, March 9, 2016, at 4:30 p.m. Eastern Standard Time to discuss fourth quarter and full year 2015 financial results and provide an update on its endocrine disease portfolio.

XOMA Corporation (NASDAQ:XOMA) belongs to Healthcare sector. Its weekly performance is -6.10%. On last trading day company shares ended up at $0.77.

Khang & Khang LLP announces that it is investigating claims of potential misrepresentations by CTI BioPharma Corp. (“CTI” or the “Company”) (NASDAQ: CTIC). The investigation focuses on whether the Company and its officers violated securities laws by issuing misleading information to investors.

CTI BioPharma Corp. (NASDAQ:CTIC) shares fell -1.93% in last trading session and ended the day at $0.67. CTIC Gross Margin is 88.20% and its return on assets is -142.60%. CTI BioPharma Corp. (NASDAQ:CTIC) quarterly performance is -39.37%.

Relypsa (NASDAQ: RLYP) reported Q4 EPS of ($1.40), $0.05 worse than the analyst estimate of ($1.35). Revenue for the quarter came in at $11.96 million versus the consensus estimate of $7.37 million.

On 24 February, Relypsa, Inc. (NASDAQ:RLYP) shares fell -2.39% and was closed at $16.78. Relypsa, Inc. (NASDAQ:RLYP) year to date (YTD) performance is -40.79%.

General Electric Company (NYSE: GE) announced the appointment of four new Company officers and one senior vice president. Effective March 1, 2016, GE will have 192 officers globally who lead large revenue-generating businesses or are in critical technology or functional roles, helping to drive growth.

General Electric Company (NYSE:GE) ended the last trading day at $28.96. Company weekly volatility is calculated as 1.54% and price to cash ratio as 2.86. General Electric Company (NYSE:GE) showed a weekly performance of -1.30%.

Summit Materials, Inc. (NYSE:SUM) announced that its indirect subsidiaries Summit Materials, LLC and Summit Materials Finance Corp. (the “Issuers”, and, together with Summit, “the Company”) intend to offer $250 million aggregate principal amount of Senior Notes due 2022 (the “notes”). The Company intends to use the proceeds from the offering to fund the acquisition of Boxley Materials Company, replenish cash used for the acquisition of American Materials Company and to pay fees and expenses incurred in connection with the offering and the acquisitions.
Summit Materials, Inc. (NYSE:SUM) shares moved up 2.09% in last trading session and ended the day at $17.07. SUM Gross Margin is 30.80% and its return on assets is 1.30%. Summit Materials, Inc. (NYSE:SUM) quarterly performance is -24.74%.

Leave a Reply

Your email address will not be published. Required fields are marked *